Proton pump inhibitors and the risk of severe adverse events – A cardiovascular bombshell?

Proton pump inhibitors are currently one of the most prescribed pharmacological classes in developed countries, given their effectiveness and safety profile, which has until now been considered favorable.However, in recent years, several papers have been published that associate prolonged use of the...

Full description

Bibliographic Details
Main Authors: Nelson Cunha, António Pedro Machado
Format: Article
Language:English
Published: Elsevier 2018-10-01
Series:Revista Portuguesa de Cardiologia (English Edition)
Online Access:http://www.sciencedirect.com/science/article/pii/S2174204918303106